Key facts
- Cohere Health’s last known valuation is $750.0M (May 2025).
- It has raised $213.1M across 5 recorded rounds; the latest was Later Stage VC ($90.0M) in May 2025.
- Notable investors include Temasek Holdings, Polaris Partners, Flare Capital Partners, Deerfield Management, Longitude Capital — 7 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Cohere Health
Funding rounds
5 roundsAbout Cohere Health
Operator of a clinical intelligence company intended to offer intelligent prior authorization by aligning physicians and health plans. The company's intelligent prior authorization is configurable for each health plan's needs and can be implemented as a fully outsourced utilization management service, providing patients and doctors with end-to-end authorization automation to digitize the process and guide care across the entire patient journey.
- Sector
- Healthcare
- HQ
- Portsmouth, NH, United States
- Founded
- 2019
- Employees
- 908
- Website
- coherehealth.com/
- Ownership
- Privately Held (backing)
Cohere Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cohere Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cohere Health in its N-PORT filings yet. We sweep new filings monthly.
Indicative levels observed on the secondary market. Private Market View is a data platform — it does not execute transactions or take buy or sell interest.